Riskpilot← Back to searchSign inGet full accessTudor Kvinnoklinik AB
ABActiveOrg 5565930400Backasjövägen 5Medical specialists activities · NACE 8622Est. 20000 employees
Revenue 2025
SEK 31K
EBITDA margin
-935.5%
-5% vs 2024
Equity ratio
96.9%
Financial strength
Net profit 2025
SEK 11,2M
+33% vs 2024
| Revenue | SEK 31K | — |
| EBITDA | SEK -290K | -5% |
| Net profit | SEK 11,2M | +33% |
| Total assets | SEK 11,9M | +12% |
| Equity | SEK 11,5M | +23% |
| Employees | 0 | — |
Legal name
Tudor Kvinnoklinik AB
Org number
5565930400
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 juni 2000
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva öppen gynekologisk läkarvårdsverksamhet, allmän läkarvårdsverksamhet, vidareutbildning och undervisning inom samma verksamheter, handel med sjukvårdsartiklar, fastighetsförvaltning, handel med värdepapper ävensom idka därmed förenlig verksamhet.
Address
Backasjövägen 5
Email
tudor@tudorkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 31 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −293 | −72 | −87 | −277 | −290 |
| Depreciation & amort. | −0 | −0 | −0 | −64 | −159 |
| EBIT | −293 | −72 | −87 | −341 | −449 |
| Net financials | 1 615 | −6 | 94 | 7 905 | 11 364 |
| Profit before tax | 1 322 | 572 | 2 570 | 8 712 | 11 266 |
| Tax | −0 | −59 | −510 | −231 | −26 |
| Net profit | 1 322 | 513 | 2 060 | 8 481 | 11 240 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 027 | 2 609 | 3 492 | 10 635 | 11 876 |
| Equity | 1 446 | 928 | 2 188 | 9 369 | 11 509 |
| Long-term debt | 141 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 340 | 1 580 | 1 304 | 916 | 367 |
| Total debt | 2 481 | 1 580 | 1 304 | 916 | 367 |
EBITDA margin
-935.5%
This company
15.8%
Market median
-6021% vs market
20212025
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
97.7%
This company
18.4%
Market median
+431% vs market
20212025
Net profit margin
36258.1%
This company
8.1%
Market median
+447531% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DD Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2026 |
| Former (1) | ||
MS Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Board of Directors | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tudor Kvinnoklinik AB 
Tudorkliniken ABBoard members of Tudor Kvinnoklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniela Dobrescu | Deputy Chief Executive Officer | 0 companies |
| Mats Stefan Svensson | Audit | 0 companies |
| Heléne Maria Kristina Dobrescu | Board of Directors | 0 companies |
| Aristide Tudor Dobrescu | Chairman | 0 companies |
| Andreas Barbu Aristide Dobrescu | Board of Directors | 0 companies |